March 29, 2000
American Chemical Society
For the first time, scientists have identified a chemical in tobacco that may explain why smokers are statistically less vulnerable to Parkinson's disease. The compound has been shown to slow the breakdown of key brain chemicals, including dopamine, which is typically depleted in the brains of patients with Parkinson's disease, according to researchers at Virginia Tech. The association between smoking and Parkinson's disease has been known for more than 20 years, but until now could not be scientifically explained.
Phenomenon long known, never before explained
The above story is based on materials provided by American Chemical Society. Note: Materials may be edited for content and length.
Cite This Page:
American Chemical Society. "Tobacco Chemical Protects Against Parkinson's Disease." ScienceDaily. ScienceDaily, 29 March 2000. <www.sciencedaily.com/releases/2000/03/000329081250.htm>.
American Chemical Society. (2000, March 29). Tobacco Chemical Protects Against Parkinson's Disease. ScienceDaily. Retrieved March 10, 2014 from www.sciencedaily.com/releases/2000/03/000329081250.htm
American Chemical Society. "Tobacco Chemical Protects Against Parkinson's Disease." ScienceDaily. www.sciencedaily.com/releases/2000/03/000329081250.htm (accessed March 10, 2014).